Abstract
Screening of pathological pregnancies with the use of biochemical markers determined in maternal serum is now widely accepted as a useful procedure. In our experience, the main contribution is a finding of abnormal values of one or more of the markers, which will advise gynecologist upon a possibility of a risk pregnancy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Biomarkers / blood*
-
Chorionic Gonadotropin / blood
-
Chromosomes, Human, Pair 18
-
Down Syndrome / blood
-
Down Syndrome / diagnosis
-
Female
-
Humans
-
Neural Tube Defects / blood
-
Neural Tube Defects / diagnosis
-
Pregnancy
-
Pregnancy-Specific beta 1-Glycoproteins / analysis
-
Prenatal Diagnosis*
-
Trisomy
-
alpha-Fetoproteins / analysis
Substances
-
Biomarkers
-
Chorionic Gonadotropin
-
Pregnancy-Specific beta 1-Glycoproteins
-
alpha-Fetoproteins